Bio-Rad Laboratories (BIO) Other Non-Current Liabilities (2016 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $199.1 million as the latest value for Q4 2025.
- Quarterly Other Non-Current Liabilities rose 12.36% to $199.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $199.1 million through Dec 2025, up 12.36% year-over-year, with the annual reading at $199.1 million for FY2025, 12.36% up from the prior year.
- Other Non-Current Liabilities for Q4 2025 was $199.1 million at Bio-Rad Laboratories, down from $207.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $228.9 million in Q1 2021, with the low at $173.1 million in Q1 2025.
- Average Other Non-Current Liabilities over 5 years is $196.7 million, with a median of $196.8 million recorded in 2022.
- The sharpest move saw Other Non-Current Liabilities soared 32.1% in 2021, then decreased 21.31% in 2022.
- Over 5 years, Other Non-Current Liabilities stood at $182.2 million in 2021, then increased by 7.53% to $195.9 million in 2022, then decreased by 0.47% to $195.0 million in 2023, then fell by 9.13% to $177.2 million in 2024, then increased by 12.36% to $199.1 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $199.1 million, $207.5 million, and $209.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.